文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.

作者信息

Bischoff S C, Mayer J, Nguyen Q T, Stolte M, Manns M P

机构信息

Department of Gastroenterology and Hepatology, Medical School of Hannover, Germany.

出版信息

Am J Gastroenterol. 1999 Dec;94(12):3521-9. doi: 10.1111/j.1572-0241.1999.01641.x.


DOI:10.1111/j.1572-0241.1999.01641.x
PMID:10606314
Abstract

OBJECTIVE: To assess the activation grade of intestinal eosinophils in patients with eosinophilic gastroenteritis (EOG), ulcerative colitis (UC), Crohn's disease (CD), and controls by immunohistochemistry. METHODS: Cecal biopsies were collected from healthy controls and from patients with EOG, CD, UC, and other noninflammatory GI diseases. Immunohistochemistry was performed in sequential sections stained with monoclonal antibodies directed against eosinophil cationic protein (ECP) or eosinophil protein X (EPX) stored in eosinophil granules (EG1) and that secreted by activated eosinophils (EG2). The ratio of EG1 to EG2-positive eosinophils expressed as percentage of lamina propria cells was calculated. ECP and EPX were measured in serum and feces. RESULTS: The percentage of EG1 and EG2-positive lamina propria cells was elevated in EOG and slightly, but not significantly, in UC. The ratio of EG1 to EG2-positive cells was decreased in CD, UC, and other patients as compared to healthy controls. Particularly low EG1 to EG2 ratios were found in EOG. Correspondingly, fecal and serum levels of ECP and EPX, respectively, were highest in patients with EOG. The EG1 to EG2 ratio was negatively correlated with fecal ECP and EPX levels. At sites of actively inflamed mucosa, the EG1 to EG2 ratio was lower than in noninflamed tissue. CONCLUSIONS: Our data strongly suggest that the EG1 to EG2 ratio may be a marker of tissue eosinophil activation. Low ratios (<1) indicate eosinophil activation, whereas ratios > or =1 are found in healthy controls. Furthermore, we show that EOG is characterized by a pronounced intestinal eosinophil accumulation and activation, whereas in CD and UC, eosinophils seem to be activated but their number is not or only slightly elevated compared to controls.

摘要

相似文献

[1]
Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.

Am J Gastroenterol. 1999-12

[2]
Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.

Am J Gastroenterol. 1999-12

[3]
Increased fecal eosinophil cationic protein in inflammatory bowel disease.

Hepatogastroenterology. 1993-6

[4]
Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.

Am J Gastroenterol. 1995-4

[5]
Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.

Am J Gastroenterol. 1999-7

[6]
Patients with psoriasis have elevated levels of serum eosinophil cationic protein and increased numbers of EG2 positive eosinophils in the duodenal stroma.

Br J Dermatol. 1996-9

[7]
Study of release of eosinophil cationic proteins (ECP and EPX) in the hypereosinophilic syndrome (HES) and other hypereosinophilic conditions.

Panminerva Med. 1998-9

[8]
Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.

J Leukoc Biol. 2008-12

[9]
Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease.

J Clin Gastroenterol. 2003-2

[10]
Activation of eosinophils in the pathophysiology of ulcerative colitis.

J Gastroenterol. 1995-11

引用本文的文献

[1]
Is Eosinophilic Colitis a Forerunner of Inflammatory Bowel Disease?

Curr Gastroenterol Rep. 2025-8-11

[2]
Rationale for an Eosinophilic Esophagitis Treat-to-Target Concept.

Gastroenterol Hepatol (N Y). 2024-10

[3]
Considering Histologic Remission in Ulcerative Colitis as a Long-Term Target.

J Clin Med. 2024-1-4

[4]
A case report of eosinophilic jejunal enteritis with spared stomach presenting as abdominal pain.

Radiol Case Rep. 2023-12-15

[5]
Review of Non-Eosinophilic Esophagitis-Eosinophilic Gastrointestinal Disease (Non-EoE-EGID) and a Case Series of Twenty-Eight Affected Patients.

Biomolecules. 2023-9-20

[6]
Eosinophilic Colitis and Sepsis With Rapid Remission After Antimicrobial Treatment; A Rare Coincidence and Its Pathogenic Implications.

Front Med (Lausanne). 2020-7-21

[7]
Outcomes of inflammatory bowel disease in patients with eosinophil-predominant colonic inflammation.

BMJ Open Gastroenterol. 2020

[8]
Fecal Eosinophil Cationic Protein Is a Diagnostic and Predictive Biomarker in Young Adults with Inflammatory Bowel Disease.

J Clin Med. 2019-11-20

[9]
Eosinophils in the gastrointestinal tract and their role in the pathogenesis of major colorectal disorders.

World J Gastroenterol. 2019-7-21

[10]
Eosinophilic Gastroenteritis: Clinical Manifestation, Natural Course, and Evaluation of Treatment with Corticosteroids and Vedolizumab.

Dig Dis Sci. 2019-4-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索